The reason why SOX9 expression was detected in metastatic lesions from SOX9− primary tumors may be the threshold of immunoreactivity of SOX9 staining; that is, there may have been a small number of SOX9+ HCC cells in the primary tumor that were not detected by immunohistochemistry. This evidence concerns the gene SOX9 and hepatocellular carcinoma.